MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 98 filers reported holding MAXCYTE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,933,144 | -32.2% | 1,260,623 | -0.3% | 0.03% | -26.8% |
| Q2 2023 | $5,801,985 | +7.5% | 1,264,049 | +15.9% | 0.04% | 0.0% |
| Q1 2023 | $5,396,995 | +4.5% | 1,090,302 | +15.2% | 0.04% | +2.5% |
| Q4 2022 | $5,166,470 | -16.8% | 946,240 | -0.9% | 0.04% | -21.6% |
| Q3 2022 | $6,208,000 | +33.8% | 955,150 | -2.6% | 0.05% | +45.7% |
| Q2 2022 | $4,640,000 | +2.3% | 981,031 | +51.2% | 0.04% | +20.7% |
| Q1 2022 | $4,534,000 | – | 648,680 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,885,000 | $5,881,200 | 5.55% |
| Vitruvian Partners LLP | 5,043,356 | $15,735,271 | 4.46% |
| Stonepine Capital Management, LLC | 3,761,640 | $11,736,317 | 3.90% |
| Mudita Advisors LLP | 1,390,858 | $4,339,477 | 3.17% |
| RIVER GLOBAL INVESTORS LLP | 1,473,254 | $4,588,359 | 1.07% |
| Casdin Capital, LLC | 1,890,000 | $5,896,800 | 0.65% |
| Portolan Capital Management | 2,143,666 | $6,688,238 | 0.62% |
| Grandeur Peak Global Advisors, LLC | 1,434,819 | $4,476,635 | 0.34% |
| First Light Asset Management, LLC | 1,073,110 | $3,348,103 | 0.32% |
| Granahan Investment Management | 1,975,847 | $6,164,643 | 0.22% |